摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(Dimethylamino)dodecanoic acid

中文名称
——
中文别名
——
英文名称
2-(Dimethylamino)dodecanoic acid
英文别名
——
2-(Dimethylamino)dodecanoic acid化学式
CAS
——
化学式
C14H29NO2
mdl
——
分子量
243.39
InChiKey
AURJQLFZBQODSR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    17
  • 可旋转键数:
    11
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Enzymatic Assays Using Umbelliferone Substrates with Cyclodextrins in Droplets of Oil
    申请人:Winger Theodore
    公开号:US20110118132A1
    公开(公告)日:2011-05-19
    The invention is directed to droplet actuator devices and assay methods. The method may include, among other things, a method of conducting enzymatic assays using umbelliferone substrates with cyclodextrins in droplets in oil, the method including incubating a droplet in oil, the droplet preferably comprising an umbelliferone substrate, a sample, and a cyclodextrin compound. The methods may further include a method of substantially eliminating cross-contamination between droplets in enzymatic containing substrate-based bioassays. The method may include immobilization of the enzymatic substrate including forming an inclusion complex with the substrate for stabilizing the substrate within an aqueous environment, wherein the inclusion complex may be formed using cyclodextrins. In yet another embodiment, the invention may provide a method of enhancing hydrolysis of enzymatic substrates. The methods may further include a method of forming an inclusion complex with the substrate for stabilizing the substrate within an aqueous environment, wherein the substrate may be a 4-MU- or HMU containing substrate. The inclusion complex may be formed using cyclodextrin.
    本发明涉及液滴操纵器件和测定方法。该方法可能包括使用环糊精在油滴中使用香豆素底物进行酶促反应的方法,该方法包括在油中孵育油滴,油滴优选包括香豆素底物,样品和环糊精化合物。该方法还可以包括在基于底物的生物测定中实现减少液滴间交叉污染的方法。该方法可能包括固定酶促底物,包括与底物形成包含复合物以稳定底物在环境中,其中可以使用环糊精形成包含复合物。在另一种实施方式中,本发明可能提供一种增强酶促底物解的方法。该方法还可以包括与底物形成包含复合物以稳定底物在环境中,其中底物可以是含4-MU或HMU的底物。包含复合物可以使用环糊精形成。
  • Method of hydrolyzing an enzymatic substrate
    申请人:Winger Theodore
    公开号:US20120136147A1
    公开(公告)日:2012-05-31
    The invention is directed to droplet actuator devices and assay methods. The method may include immobilization of the enzymatic substrate including forming an inclusion complex with the substrate within an aqueous environment in contact with an oil.
    这项发明涉及液滴操作器件和检测方法。该方法可能包括将酶底物固定,包括在与油接触的环境中形成与底物的包含物复合物。
  • Method of Conducting an Assay
    申请人:Advanced Liquid Logic, Inc.
    公开号:US20140141460A1
    公开(公告)日:2014-05-22
    The invention is directed to droplet actuator devices and assay methods. The invention includes assay methods of conducting an assay comprising combining a sample with an umbelliferyl derivative, wherein the sample potentially comprises an enzyme capable of cleaving the umbelliferyl derivative and where the umbelliferyl derivative comprises an umbelliferyl core modified with one or more modifying moieties.
    这项发明涉及液滴驱动器装置和测定方法。该发明包括进行测定的测定方法,其中将样品与香豆素生物结合,其中样品可能包含能够切割香豆素生物的酶,并且香豆素生物包括一个或多个修饰基团修饰的香豆素核心。
  • Enzyme Assays on a Droplet Actuator
    申请人:ADVANCED LIQUID LOGIC, INC.
    公开号:US20150184219A1
    公开(公告)日:2015-07-02
    The invention is directed to droplet actuator devices and assay methods. The invention includes assay methods of conducting an assay comprising combining a sample with an umbelliferyl derivative, wherein the sample potentially comprises an enzyme capable of cleaving the umbelliferyl derivative and where the umbelliferyl derivative comprises an umbelliferyl core modified with one or more modifying moieties.
    本发明涉及液滴驱动器装置和检测方法。本发明包括检测方法,用于进行检测,包括将样品与香豆素生物结合,其中样品可能包含能够裂解香豆素生物的酶,并且香豆素生物包括经过一个或多个修饰基修饰的香豆素核心。
  • MEDICINAL COMPOSITION FOR PERCUTANEOUS ADMINISTRATION
    申请人:DAIICHI PHARMACEUTICAL CO., LTD.
    公开号:EP1043020A1
    公开(公告)日:2000-10-11
    A percutaneously absorbable medicinal composition comprising a percutaneous absorption enhancer and at least one member selected from the group consisting of aromatic amidine derivatives represented by formula (1): salts of the derivatives, solvates of the derivatives, and solvates of salts of the derivatives. The present invention provides a composition which exhibits high percutaneous absorbability, which can maintain an effective blood level for prolonged periods of time, which provides antithrombotic and anticoagulant effects.
    一种经皮吸收的药物组合物,包括经皮吸收增强剂以及选择自式(1)所表示的芳香族酰胺衍生物的至少一种成员:衍生物的盐,衍生物的溶剂,以及衍生物的盐的溶剂。本发明提供了一种组合物,具有高经皮吸收性,可以维持有效的血液平长时间,具有抗血栓和抗凝血作用。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸